Henry Withers of Roswell Park Cancer Institute, Department of Genetics discusses how the data can predict which patients are at risk for metastatic disease and his hopes for a potential biomarker that can be used to identify patients with aggressive prostate cancer. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Data Helps Predict Which Patients Are At Risk For Metastatic Disease
